Vigil Health Solutions Inc. (“Vigil”) announces
the results of operations for the quarter ending June 30, 2020.
Developments in the
Quarter
- Revenue of $1.25 million compared
to $1.32 million in the three month period ended June 30,
2019.
- Earnings before income taxes were
$172 thousand compared to losses of $62 thousand in the three month
period ended June 30, 2019.
- Sales bookings for the quarter were
$1.21 million compared to $1.47 million in the three month period
ended June 30, 2019.
- Adjusted EBITDA of $232 thousand
compared to negative Adjusted EBITDA of $18 thousand in the three
months ended June 30, 2019.
“When we reported our Q1 results a year ago,
senior housing construction was experiencing what was expected to
be a temporary slowdown and the challenges that the pandemic would
present were unimaginable. In the three months ended June 30, 2020,
senior housing occupancy and new construction fell to historically
low levels. However, with approximately a quarter of worldwide
COVID-19 cases in the United States, delivering reliable technology
to the senior living industry has never been more important.
“Vigil’s priority continues to be the health and
wellbeing of our staff, our customers, and the seniors they serve.
Capitalizing on our strong corporate partnerships and customer
service we have worked closely with our clients to best manage new
installations and service existing sites in this new environment.
In addition to completing eight new nurse call installations in the
quarter we closed $1.21 million in new sales bookings.
“Our customers can access our teams as
effortlessly as when they were located in our head office, we have
upgraded our online training and remote commissioning and continue
to develop products that will provide long term value to our
customers. While we expect delays in project commissioning and
slower construction for some time, we believe the long term
fundamentals of senior housing remain strong and that we are
positioned well for the future,” stated Troy Griffiths, President
and CEO of Vigil Health Solutions Inc.
Financial Results
Revenue for the three months ended June 30, 2020
was $1.25 million compared to $1.32 million in the three month
period ended June 30, 2019. Project revenue from new and existing
customers made up 45% of total revenue, compared to 43% in the
three month period ended June 30, 2019. The small decline related
to a decrease in follow on sales to existing customers, these
include service and maintenance billings and replacement products
including wireless devices and communication equipment.
Sales bookings for the quarter were $1.21
million down 18% from $1.47 million in the three month period ended
June 30, 2019. There were 9 project sales with an average value of
$62 thousand compared to 12 project sales with an average value of
$62 thousand in the period ending June 30, 2019.
At June 30, 2020 Vigil had a backlog of
approximately $3.81 million (including $1.69 million in deposits
and progress billings, recorded as deferred revenue on the balance
sheet) compared to approximately $3.08 million (including $866
thousand in deposits and progress billings, recorded as deferred
revenue on the balance sheet) at June 30, 2019. Vigil’s backlog
included 36 projects at varying stages of installation and progress
billing with an average size of $106 thousand compared to 31
projects with an average size of $99 thousand at June 30, 2019. The
Company’s backlog is the total estimated revenue for contracts
which are signed, and have not been completed (and may not have
commenced).
The gross margin percentage was 54% for the
three months ended June 30, 2020 and 2019.
Operating expenditures for the three months
ended June 30, 2020 were $462 thousand down 41% from $776 thousand
for the period ended June 30, 2019. The decrease reflected the
Canada Emergency Wage Subsidy (CEWS) payments, recorded as a
reduction in payroll expense. There were also large declines in
sales and marketing expenses following reduced travel and tradeshow
cancelations due to COVID-19 restrictions.
Earnings before income taxes were $172 thousand
compared to losses of $62 thousand in the three month period ended
June 30, 2019. The earnings reflect the $193 thousand CEWS subsidy.
Net earnings and comprehensive income were $121 thousand or $0.007
per share compared to a net loss of $62 thousand, or $0.003 per
share for the three month period ended June 30, 2019.
Detailed financial statements along with
Management Discussion and Analysis have been filed with SEDAR
(www.sedar.com).
Financial information will be mailed to entitled security
holders on August 30, 2020, or, upon notice to the Company,
entitled security holders may request a copy of financials in
advance.
Summary Financial Information
|
|
June 30, |
|
|
June 30, |
|
|
|
2020 |
|
|
2019 |
|
|
|
(unaudited) |
|
|
(unaudited) |
|
|
|
|
|
|
Revenue |
$ |
1,251,861 |
|
$ |
1,322,584 |
|
|
|
|
|
|
Cost of sales |
|
581,934 |
|
|
603,970 |
|
|
|
|
|
|
Gross
profit |
|
669,927 |
|
|
718,614 |
|
|
|
|
|
|
Expenses |
|
461,850 |
|
|
776,291 |
|
|
|
|
|
|
Income
(loss) before the following items |
|
208,077 |
|
|
(57,677 |
) |
|
|
|
|
|
Other income (expense): |
|
(36,462 |
) |
|
(3,934 |
) |
|
|
|
|
|
Earnings
(loss) before income taxes |
|
171,615 |
|
|
(61,611 |
) |
|
|
|
|
|
Income
taxes |
|
(50,861 |
) |
|
- |
|
|
|
|
|
|
Net earnings (loss) and comprehensive income (loss) for the
period |
$ |
120,754 |
|
$ |
(61,611 |
) |
|
|
|
|
|
|
|
Non-IFRS Measure
For the three months ended June 30, 2020, we are
disclosing Adjusted EBITDA, a non-IFRS financial measure, as a
supplementary indicator of operating performance. We define
Adjusted EBITDA as net income before, interest, income taxes,
amortization excluding amortization of right of use asset for the
lease on the Company’s head office, stock based compensation and
currency gains or losses including derivative foreign exchange
differences. We are presenting the non-IFRS financial measure in
our filings because we use it internally to make strategic
decisions, forecast future results and to evaluate our performance
and because we believe that our current and potential investors and
analysts use the measure to assess current and future operating
results and to make investment decisions. It is a non-IFRS
measure, may not be comparable to other companies and it is not
intended as a substitute for IFRS measures.
Adjusted EBITDA Reconciliation
|
|
Three months ended |
|
|
June 30, 2020 |
|
|
June 30, 2019 |
|
|
|
|
|
|
|
|
Income for the period |
$ |
120,754 |
|
$ |
(61,611 |
) |
|
|
|
|
|
Add / (deduct) |
|
|
|
|
Foreign exchange |
|
42,894 |
|
|
15,074 |
|
Change in fair value of derivative |
|
(7,961 |
) |
|
(2,770 |
) |
Interest |
|
1,529 |
|
|
(8,571 |
) |
Tax |
|
50,861 |
|
|
- |
|
Stock based compensation |
|
12,712 |
|
|
28,059 |
|
Amortization |
|
11,235 |
|
|
12,181 |
|
|
|
111,270 |
|
|
43,973 |
|
|
|
|
|
|
Adjusted EBITDA |
$ |
232,024 |
|
$ |
(17,638 |
) |
|
|
|
|
|
|
|
About Vigil Health Solutions
Inc.
Vigil offers a proprietary technology platform
combining software and hardware to provide comprehensive solutions
to the expanding seniors’ housing market. Vigil has established a
growing presence in North America and an international reputation
for being on the leading edge of systems design and integration.
Vigil’s objective is to offer solutions for the full continuum of
care. Vigil’s product range includes the innovative wireless
Vitality Care System™ featuring discreet 'mini pendants', a nurse
call system, mobile fall and incontinence monitoring, resident
check in and the award-winning Vigil Memory Care System.
Certain statements contained in this news
release that are not based on historical facts may constitute
forward-looking statements or forward-looking information within
the meaning of applicable securities laws (“forward-looking
statements”). These forward-looking statements are not
promises or guarantees of future performance but are only
predictions that relate to future events, conditions or
circumstances or our future results, performance, achievements or
developments and are subject to substantial known and unknown
risks, assumptions, uncertainties and other factors that could
cause our actual results, performance, achievements or developments
in our business or in our industry to differ materially from those
expressed, anticipated or implied by such forward-looking
statements.
Forward-looking statements include all financial
guidance, disclosure regarding possible events, conditions,
circumstances or results of operations that are based on
assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance
upon any such forward-looking statements, which speak only as of
the date they are made. These forward-looking statements appear in
a number of different places in this presentation and can be
identified by words such as “may”, “estimates”, “projects”,
“expects”, “intends”, “believes”, “plans”, “anticipates”, or their
negatives or other comparable words. Forward-looking statements
include statements regarding the outlook for our future operations,
plans and timing for the introduction or enhancement of our
services and products, statements concerning strategies or
developments, statements about future market conditions, supply
conditions, end customer demand conditions, channel inventory and
sell through, revenue, gross margin, operating expenses, profits,
forecasts of future costs and expenditures, the outcome of legal
proceedings, and other expectations, intentions and plans that are
not historical fact.
The risk factors and uncertainties that may
affect our actual results, performance, achievements or
developments are many and include, amongst others, our ability to
develop our sales force and generate revenue, the length of the
sales cycle, management of the Company’s growth, ability to recruit
and retain staff, fluctuations in demand for current and future
products, our ability to develop, manufacture, supply and market
existing and new products that meet the needs of customers,
volatility in the exchange rate, ability to secure financing,
ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in
regulation and reliance on third party suppliers. These risk
factors and others, including the updated risks related to the
COVID-19 pandemic, are discussed in the Risks and Uncertainties
section of our “Management Discussion and Analysis” segment of our
fiscal 2020 Annual Report. Many of these factors and uncertainties
are beyond the control of the Company. Consequently, all
forward-looking statements in this news release are qualified by
this cautionary statement and there can be no assurance that actual
results, performance, achievements or developments anticipated by
the Company will be realized.
We caution readers that the risks described are
not the only ones that could impact the Company. We cannot
accurately predict the full impact that COVID-19 will have on our
business, results of operations, financial condition or the demand
for our services, due in part to the uncertainties relating to the
ultimate geographic spread of the virus, the severity of the
disease, the duration of the outbreak, the steps our
customers and suppliers may take in current circumstances,
including slowing or halting operations, the duration of travel and
quarantine restrictions imposed by governments of affected
countries and other steps that may be taken by such governments to
respond to the pandemic. Additional risks and uncertainties not
currently known to us or that are currently deemed to be immaterial
may also have a material adverse effect on our business, financial
condition, or results of operations.
Forward-looking statements are based on
management’s current plans, estimates, projections, beliefs and
opinions and, except as required by law, the Company does not
undertake any obligation to update forward-looking statements
should the assumptions related to these plans, estimates,
projections, beliefs and opinions change.
For further information please contact:Troy Griffiths, President
and CEOTel: (250) 383-6900Fax: (250) 383-6999Email:
information@vigil.com |
Vigil Health Solutions Inc.2102-4464 Markham StreetVictoria, BCV8Z
7X8Website: www.vigil.com |
|
|
The TSX Venture Exchange has not reviewed and
does not accept responsibility for the adequacy or accuracy of this
release.
Vigil Health Solutions (TSXV:VGL)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Vigil Health Solutions (TSXV:VGL)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024